HCPCS code J9061 — Inj, amivantamab-vmjw. Status: Active. Effective Jan 1, 2022. Source: CMS HCPCS Level II.

J9061

Active

Inj, amivantamab-vmjw

Injection, amivantamab-vmjw, 2 mg

Category: Drugs
Section: J-codes: Drugs Administered Other Than Oral Method
Effective: Jan 1, 2022
Code type: alphanumeric
OPPS Status: K — Non-pass-through drugs and biologicals
OPPS APC: 9432

MUE — Medically Unlikely Edits

Maximum units of J9061 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.

Service Type Max Units / Day
DME Supplier 1050
Outpatient Hospital 1050
Practitioner Services 1050

Source: CMS Medicare NCCI Medically Unlikely Edits

NDC Crosswalk

National Drug Codes (NDCs) mapped to this HCPCS code.

NDC Drug Name
57894-0501-01 Rybrevant

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2022-Q1
    Inj, amivantamab-vmjw